Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Max Healthcare InstituteNSE:MAXHEALTH +0.58%93 PS Ratio is 11.37 as of Aug. 14, 2026, which is 1% below its 10-year median of 11.49. GuruFocus rates NSE:MAXHEALTH with a GF Score™ of 93/100 and a GF Value™ of ₹1,422.22 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 656 Healthcare Providers & Services companies, Max Healthcare Institute ranks worse than 93.45% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Max Healthcare Institute's share price is ₹1013.30.
Max Healthcare Institute's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹89.14. Hence, Max Healthcare Institute's PS Ratio for today is 11.37.
Good Sign:
Max Healthcare Institute Ltd stock PS Ratio (=11.32) is close to 3-year low of 11.02.
The historical rank and industry rank for Max Healthcare Institute's PS Ratio or its related term are showing as below:
NSE:MAXHEALTH'
s PS Ratio Range Over the Past 10 Years
Min: 5.1 Med: 11.49 Max: 19.5
Current: 11.32
During the past 12 years, Max Healthcare Institute's highest PS Ratio was 19.50. The lowest was 5.10. And the median was 11.49.
NSE:MAXHEALTH's PS Ratio is ranked worse than 93.45% of 656
companies
in the Healthcare Providers & Services industry
Industry Median: 1.56
vs NSE:MAXHEALTH: 11.32
During the past 12 months, the average Revenue per Share Growth Rate of Max Healthcare Institute was 16.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 22.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 23.00% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 13.00% per year.
During the past 12 years, Max Healthcare Institute's highest 3-Year average Revenue per Share Growth Rate was 26.60% per year. The lowest was -4.70% per year. And the median was 15.40% per year.
Max Healthcare Institute (NSE:MAXHEALTH) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MAXHEALTH vs HCA, THC, DVA: PS Ratio Comparison
For the Medical Care Facilities subindustry, Max Healthcare Institute's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Max Healthcare Institute PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Max Healthcare Institute's PS Ratio distribution charts can be found below:
* The bar in red indicates where Max Healthcare Institute's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Max Healthcare Institute's Share Price of today is ₹1013.30. Max Healthcare Institute's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹89.14.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Max Healthcare Institute (NSE:MAXHEALTH) has a PS Ratio of 11.37 as of Aug. 14, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Max Healthcare Institute and its competitors. This is near median its historical median of 11.49. Over the past decade, Max Healthcare Institute's PS Ratio has ranged from 5.10 to 19.50. According to the industry distribution chart, Max Healthcare Institute ranks #613 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 93.4%.
Is Max Healthcare Institute's PS Ratio too high?
Max Healthcare Institute's current PS Ratio of 11.37 is near median its 10-year median of 11.49. Over the past 10 years, this metric has ranged from a low of 5.10 to a high of 19.50. The Healthcare Providers & Services industry median PS Ratio is 1.56. Max Healthcare Institute's value of 11.37 is 628.8% above this industry median. Based on the distribution chart, Max Healthcare Institute ranks #613 out of 656 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Max Healthcare Institute has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Max Healthcare Institute's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Max Healthcare Institute ranks #613 out of 656 companies for PS Ratio. This places Max Healthcare Institute in the lower half of its industry. The industry median PS Ratio is 1.56. Max Healthcare Institute's value of 11.37 is 628.8% above this benchmark. Historically, Max Healthcare Institute's own PS Ratio has ranged from 5.10 to 19.50 over the past decade. While the company's 10-year median is 11.49 vs. the industry median of 1.56, Max Healthcare Institute has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.56, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Max Healthcare Institute's current PS Ratio of 11.37 is 628.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Max Healthcare Institute and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Max Healthcare Institute's current PS Ratio is 11.37, which is near median its own 10-year median of 11.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Max Healthcare Institute stock overvalued right now?
Based on GuruFocus' analysis, Max Healthcare Institute (NSE:MAXHEALTH) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,422.22, compared to a current price of ₹1,013.30 — trading 28.8% below its estimated fair value. The current PS Ratio is 11.37, which is near median its 10-year median of 11.49 and 628.8% above the Healthcare Providers & Services industry median of 1.56. Max Healthcare Institute's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Max Healthcare Institute (NSE:MAXHEALTH), the current PS Ratio is 11.37 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Max Healthcare Institute (NSE:MAXHEALTH) Overvalued in 2026?
Based on GuruFocus' analysis, Max Healthcare Institute stock appears to be undervalued.
The current stock price of ₹1,013.30 is trading 28.8% below its estimated GF Value™ of ₹1,422.22.
GuruFocus considers Max Healthcare Institute to be Modestly Undervalued.
Key valuation signals for NSE:MAXHEALTH:
PS Ratio: 11.37 (near median its 10-year median of 11.49)
GF Value™: ₹1,422.22 vs. price of ₹1,013.30 (28.8% below fair value)
Industry Position: 628.8% above the Healthcare Providers & Services median (#613 of 656)
No single metric tells the full story. See the NSE:MAXHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Max Healthcare Institute Ltd is a health care service provider. The company's facilities include third-party healthcare providers with whom the company has entered long-term service contracts for providing clinical, radiology, and pathology services. Its hospitals provide the full range of services through its Outpatient, Day Care, Emergency Room, and In-Patient departments to accommodate medical specialties such as orthopedics, internal medicine, general surgery, cardiac sciences, oncology, neurosciences, and obstetrics, as well as diagnostics. The group derives revenue from India.
93GF Score
Get the complete analysis for NSE:MAXHEALTH
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MAXHEALTH has been successfully added to your 
